Aidapak Recalls Niacin Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling Niacin 100 mg tablets that may be mislabeled as GuaiFENesin ER 600 mg. The recall covers repacked drugs distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported injuries or illnesses, which aligns with the rubric for moderate severity involving minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is recalling Niacin, Tablet, 100 mg, Over The Counter (NDC 00904227160) due to a potential labeling error. The recall is initiated because the product may have been mislabeled as guaiFENesin ER, Tablet, 600 mg (NDC 63824000815).
The affected Niacin tablets have the pedigree W002661 and an expiration date of 6/5/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The agency has classified this recall as Class II.
Consumers who possess the recalled Niacin tablets should stop using them and contact their pharmacist or the recalling firm for instructions on how to return the product.
The recalled product
- Product
- NIACIN, Tablet, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904227160.
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- NIACIN
- Tablet
- 100 mg has the following codes: Pedigree: W002661
- EXP: 6/5/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAidapak Recalls GuaiFENesin ER Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateFDA Recalls GuaiFENesin ER Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Niacin TR Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Guanfacine Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- HighAidapak Recalls GuaiFENesin ER Tablets Due to Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Atorvastatin Calcium Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-22